Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexa B Schrock

Showing results (91-100 of 130) with videos related to

Pageof 13
Sort By:
The Journal of Molecular Diagnostics : JMD|January 4, 2026
Phenotypic POLE variant classification identifies patients who may have favorable prognosis and benefit from immunotherapyRachel B Keller-Evans, Zoe Fleischmann, Smruthy Sivakumar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2022
Activating IGF1R hotspot non-frameshift insertions define a novel, potentially targetable molecular subtype of adenoid cystic carcinomaMatthew Margolis, Tyler Janovitz, Jason Laird, et al.
The Oncologist|February 18, 2017
Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase FusionsPierre Vanden Borre, Alexa B Schrock, Peter M Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2018
Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or AnusAlexa B Schrock, Dean Pavlick, Samuel J Klempner, et al.
European Urology Focus|July 21, 2018
Genomic Characterization of Testicular Germ Cell Tumors Relapsing After ChemotherapyAndrea Necchi, Gennady Bratslavsky, Robert J Corona, et al.
Cancer Discovery|February 17, 2022
The Genomics of Colorectal Cancer in Populations with African and European AncestryParvathi A Myer, Jessica K Lee, Russell W Madison, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 9, 2018
Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLCJonathan W Riess, David R Gandara, Garrett M Frampton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2017
<sup>Non-V600</sup> BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal CancerJeremy C Jones, Lindsay A Renfro, Humaid O Al-Shamsi, et al.
The Journal of Urology|October 7, 2018
Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic TherapyJoseph M Jacob, Elizabeth K Ferry, Laurie M Gay, et al.
JCO Precision Oncology|July 9, 2025
LODESTAR: A Single-Arm Phase II Study of Rucaparib in Solid Tumors With Pathogenic Germline or Somatic Variants in Homologous Recombination Repair GenesSriram Anbil, Nicholas J Seewald, E Gabriela Chiorean, et al.
Pageof 13

Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
The Journal of Molecular Diagnostics : JMD|January 4, 2026
Phenotypic POLE variant classification identifies patients who may have favorable prognosis and benefit from immunotherapyRachel B Keller-Evans, Zoe Fleischmann, Smruthy Sivakumar, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2022
Activating IGF1R hotspot non-frameshift insertions define a novel, potentially targetable molecular subtype of adenoid cystic carcinomaMatthew Margolis, Tyler Janovitz, Jason Laird, et al.
The Oncologist|February 18, 2017
Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase FusionsPierre Vanden Borre, Alexa B Schrock, Peter M Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2018
Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or AnusAlexa B Schrock, Dean Pavlick, Samuel J Klempner, et al.
European Urology Focus|July 21, 2018
Genomic Characterization of Testicular Germ Cell Tumors Relapsing After ChemotherapyAndrea Necchi, Gennady Bratslavsky, Robert J Corona, et al.
Cancer Discovery|February 17, 2022
The Genomics of Colorectal Cancer in Populations with African and European AncestryParvathi A Myer, Jessica K Lee, Russell W Madison, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 9, 2018
Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLCJonathan W Riess, David R Gandara, Garrett M Frampton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2017
<sup>Non-V600</sup> BRAF Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal CancerJeremy C Jones, Lindsay A Renfro, Humaid O Al-Shamsi, et al.
The Journal of Urology|October 7, 2018
Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic TherapyJoseph M Jacob, Elizabeth K Ferry, Laurie M Gay, et al.
JCO Precision Oncology|July 9, 2025
LODESTAR: A Single-Arm Phase II Study of Rucaparib in Solid Tumors With Pathogenic Germline or Somatic Variants in Homologous Recombination Repair GenesSriram Anbil, Nicholas J Seewald, E Gabriela Chiorean, et al.
Pageof 13